We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value for our company, our shareholders and society.
First quarter results 2026
April 28, 2026 | Basel, Switzerland
Press release: English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB)
Interim financial report (PDF 0.3 MB)
Watch the webcast
Download the presentation (PDF 5.1 MB)
Download the podcast (MP3 26 MB)
Download 2026 epidemiology data (PDF 0.7 MB)
Novartis Q1 2026 impact and sustainability update (PDF 1.6 MB)
Investors event calendar
View recent presentations and learn more about upcoming events.
May 12, 2026
Redburn Global Equities Conference
Toronto, Canada
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: May 2026 (PDF 1,6 MB) | February 2026 (PDF 1.1 MB) | November 2025 (PDF 0.8 MB) | July 2025 (PDF 0.8 MB) | May 2025 (PDF 0.9 MB)
Latest updates: Social Impact & Sustainability(PDF 2.1 MB) | Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.